Lindy Biosciences

Biotechnology, Product Research, Therapeutics
Founded in 1/1/17
Durham, North Carolina, United States
For Profit

About Lindy Biosciences

Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 6646236 USD
  • Last Funding: 3200000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Lindy Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Product Research, Therapeutics

Headquarters: Durham, North Carolina, United States